Elvira Müller, PhD, MPH

Elvira Müller is Vice President within Certara’s Evidence & Access group, responsible for HTA and Evidence Development while managing Certara’s consulting team base in Germany. Besides numerous HTA engagements, she has substantial experience in EUnetHTA collaboration as well as in European Joint Clinical Assessments (JCA) and Joint Scientific Consultation (JSC). She has 20+ years of experience in global market access, applying her senior expertise in providing high-quality scientific advice to optimize the value of pharmaceuticals and medical technologies. Elvira holds an MSc and PhD in Biology and Toxicology from Würzburg University and an MPH from Ulm University.